Habib, G, Hoen, B, Tornos, P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J
2009; 30: 2369–2413.
Danchin, N. Prophylaxis of infective endocarditis: French recommendations 2002. Heart
2005; 91: 715–718.
Wilson, W, Taubert, KA, Gewitz, M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation
2007; 116: 1736–1754.
Duval, X, Delahaye, F, Alla, F, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications. J Am Coll Cardiol
2012; 59: 1968–1976.
DeSimone, DC, Tleyjeh, IM, Correa de Sa, DD, et al. Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association’s endocarditis prevention guidelines. Circulation
2012; 126: 60–64.
Bikdeli, B, Wang, Y, Kim, N, Desai, MM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol
2013; 62: 2217–2226.
Thornhill, MH, Dayer, MJ, Forde, JM, et al. Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study. BMJ
2011; 342: d2392.
Pasquali, SK, He, X, Mohamad, Z, et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Am Heart J
2012; 163: 894–899.
Dayer, MJ, Jones, S, Prendergast, B, Baddour, LM, Lockhart, PB, Thornhill, MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet
2015; 385: 1219–1228.
Pant, S, Patel, NJ, Deshmukh, A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol
2015; 65: 2070–2076.
Morse, RB, Hall, M, Fieldston, ES, et al. Children’s hospitals with shorter lengths of stay do not have higher readmission rates. J Pediatr
2013; 163: 1034–1038.
Berry, JG, Hall, DE, Kuo, DZ, et al. Hospital utilization and characteristics of patients experiencing recurrent readmissions within children’s hospitals. JAMA
2011; 305: 682–690.
Pasquali, SK, Li, JS, He, X, et al. Perioperative methylprednisolone and outcome in neonates undergoing heart surgery. Pediatrics
2012; 129: e385–e391.
Baddour, LM, Wilson, WR, Bayer, AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation
2005; 111: e394–e434.
Jenkins, KJ, Gauvreau, K, Newburger, JW, Spray, TL, Moller, JH, Iezzoni, LI. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg
2002; 123: 110–118.
Pharis, CS, Conway, J, Warren, AE, Bullock, A, Mackie, AS. The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J
2011; 161: 123–129.
Naik, RJ, Patel, NR, Wang, M, Shah, NC. Infective endocarditis prophylaxis: current practice trend among paediatric cardiologists: are we following the 2007 guidelines?
2015; 93: 1–7.